With the clock ticking on a European Commission probe into Google’s $2.1 billion bid for Fitbit, the tech giant offered regulators a concession late Monday, agreeing not to use Fitbit’s trove of health data to help target ads.
Google had been staring down the possibility of a sweeping antitrust investigation by European regulators that was the latest in a series of probes into its deal with Fitbit announced last November. But the tech giant had a potential way to avoid the full thrust of the investigation: A promise, in the form of a binding pledge, not to use Fitbit’s fitness data for ad-targeting. Regulators gave the company until Monday to offer such a statement. Google complied late that day, Reuters reported.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
What is it?
STAT Plus is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
